Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Prospective Randomised Multicenter Study for Therapy Optimization (First Line) of Advanced Progredient, Low Malignant Non-Hodgkin Lymphomas and Mantle Cell Lymphomas.

Next Previous
X
Search
Trial Profile

Prospective Randomised Multicenter Study for Therapy Optimization (First Line) of Advanced Progredient, Low Malignant Non-Hodgkin Lymphomas and Mantle Cell Lymphomas.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 26 Aug 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bendamustine (Primary) ; Rituximab (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Vincristine
  • Indications Follicular lymphoma; Lymphoid leukaemia; Mantle-cell lymphoma; Marginal zone B-cell lymphoma
  • Focus Registrational; Therapeutic Use
  • Acronyms StiL NHL1 study

    • Most Recent Events

    • 04 Dec 2018 Results assessing the Prognostic Value of Circulating Bcl-2/Igh Levels before and after Treatment in Patients with Advanced Follicular Lymphoma Receiving First-Line Immuno-Chemotherapy in 2 Prospective StiLTrials (n=415) presented at the 60th Annual Meeting and Exposition of the American Society of Hematology
    • 06 Jun 2017 Nine-years results of patients with indolent lymphomas (n=447) presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
    • 21 Feb 2013 Results published in Lancet.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top